Posts by: Charles Moore

Charles Moore

Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.

April 21, 2017

RedHill Wins Two More U.S. Patents on Gastrointestinal Therapy BEKINDA

News

RedHill Biopharma has received two more U.S. patents for its gastrointestinal therapy BEKINDA (ondansetron). The patents cover RedHill’s propriety formulation of its extended-release ondansetron tablet, and the way BEKINDA is ... Read more

April 6, 2017April 6, 2017

Finch, Takeda to Jointly Develop Microbiome Therapeutic for Ulcerative Colitis

News

Japan’s Takeda Pharmaceutical and Boston-based Finch Therapeutics will jointly develop the drug FIN-524 to treat ulcerative colitis, a form of inflammatory bowel disease (IBD). FIN-524 is Finch’s first microbiotic product candidate. The company says its live biotherapeutic product ... Read more

February 27, 2017

Cellceutix’s IBD Therapy Brilacidin Progresses to Highest Dose Group in Phase 2 Trial

News

Cellceutix says the ongoing Phase 2 clinical trial of its lead drug candidate Brilacidin has progressed to its third cohort (highest dose) to induce remission of mild-to-moderate ulcerative colitis, now that the study’s Safety Committee has ... Read more

November 30, 2016

NFL Suspends Buffalo Bills Player for Using Medical Marijuana to Treat Crohn’s Pain

News

National Football League Buffalo Bills offensive tackle Seantrel Henderson, who has been diagnosed with Crohn’s disease, has been suspended for using marijuana, a violation of the NFL’s Policy and Program for Substances ... Read more

August 26, 2016August 26, 2016

Peptide-Based Oral Drugs for Bowel Diseases Closer to Development

Crohn's Disease, IBD News, News, Ulcerative colitis

University of Queensland‘s spin-off biotech company Protagonist Therapeutics is getting closer to developing peptide-based first-in-class oral drugs for treating inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC). The oral therapy has ... Read more

August 19, 2016August 19, 2016

Ginger Nanoparticles May Be Inexpensive, Nontoxic IBD Treatment, VA Researchers Say

Colon Cancer, Crohn's Disease, IBD News, News, Ulcerative colitis

A study by researchers at the Atlanta VA Medical Center revealed that nanoparticles derived from fresh ginger root may be an effective treatment for Crohn’s disease and ulcerative colitis. In ... Read more

August 8, 2016August 8, 2016

Vitality Biopharma Developing Cannabis-derived Prodrugs for Inflammatory Bowel Disease

News

Vitality Biopharma of California has developed a new class of cannabis-derived cannabinoid prodrugs, known as cannabosides, which can enable the selective delivery of cannabidiol (CBD), a cannabinoid compound, to the intestinal tract, ... Read more

July 28, 2016

To Raise Awareness of IBD, Soccer Star Brandi Chastain and AbbVie Create ‘Game Plan’

News

Brandi Chastain, a former member of the United States women’s national soccer team and a retired world class professional soccer player recently elected to the U.S. Soccer Hall of Fame, ... Read more

July 26, 2016July 26, 2016

Craft Brewery’s Feast of Saint Arnold Raises $106,000 for IBD Center at Texas Children’s Hospital

Crohn's Disease, IBD News, News, Ulcerative colitis

The oldest craft brewery in Texas, Houston-based Saint Arnold Brewing Co., reported that its 2016 Feast of Saint Arnold raised $106,000 for the Texas Children’s Hospital Inflammatory Bowel Disease (IBD) Center. ... Read more

June 24, 2016June 24, 2016

InformTx Therapeutic Drug Monitoring for IBD Patients Launched by Miraca Life Sciences

IBD News, News

Miraca Life Sciences, an independent anatomic pathology lab based in Irving, Texas, is expanding into clinical pathology testing for patients with inflammatory bowel disease (IBD). Miraca’s new InformTx therapeutic drug monitoring ... Read more